Contact this trialFirst, we need to learn more about you.
Anti-inflammatory
BRS201 for Ulcerative Colitis
Recruiting1 awardPhase 2
Chestnut Hill, Massachusetts
This trial is testing the drug BRS201 as a treatment for severe ulcerative colitis in adults who have not responded to other treatments. Participants will take the study drug orally for 4 weeks and
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service